Schrödinger, Inc. (SDGR)
Schrödinger, Inc.
1540 Broadway
24th Floor
New York, NY 10036
United States
212 295 5800
https://www.schrodinger.com
Sector(es): Healthcare
Industria: Health Information Services
Empleados a tiempo completo: 867
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Ramy Farid Ph.D. | CEO, President & Director | 1.06M | 1.14M | 1965 |
| Dr. Richard A. Friesner Ph.D. | Co-Founder, Scientific Advisory Chairman and Director | 465k | N/D | 1953 |
| Dr. Geoffrey Craig Porges MBBS | Executive VP & CFO | 888.15k | N/D | N/D |
| Dr. Robert Lorne Abel Ph.D. | Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D | 569.45k | N/D | 1982 |
| Dr. Karen Akinsanya Ph.D. | President of Research & Development Therapeutics | 797.74k | N/D | 1968 |
| Dr. Margaret Han Dugan M.D. | Chief Medical Officer | 707.46k | N/D | 1957 |
| Prof. William Goddard III | Co-Founder & Scientific Advisor | N/D | N/D | N/D |
| Mr. Kenneth Patrick Lorton | Executive VP, CTO & COO of Software | 510.09k | 395.9k | 1984 |
| Mr. Shane Brauner | Executive VP & Chief Information Officer | N/D | N/D | 1978 |
| Ms. Jaren Irene Madden | Senior Vice President of Investor Relations & Corporate Communications | N/D | N/D | N/D |
Descripción
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Gestión corporativa
La calificación ISS Governance QuickScore de Schrödinger, Inc. a partir del 1 de mayo de 2024 es 6. Las puntuaciones principales son Auditoría: 6; Junta: 6; Derechos del accionista: 3; Compensación: 9.
